Index of artpub/2021/272119/

Ljungman, Per
A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipients
2021
https://ddd.uab.cat/record/272119